The untapped potential of Gallium 68-PET: The next wave of 68Ga-agents
DL Smith, WAP Breeman, J Sims-Mourtada - Applied Radiation and …, 2013 - Elsevier
68Gallium-PET (68Ga-PET) agents have significant clinical promise. The radionuclide can
be produced from a 68Ge/68Ga generator on site and is a convenient alternative to …
be produced from a 68Ge/68Ga generator on site and is a convenient alternative to …
Gallium-68 in medical imaging
L Martiniova, LD Palatis, E Etchebehere… - Current …, 2016 - ingentaconnect.com
Over the past several years, Positron Emission Tomography (PET) imaging agents labeled
with 68Gallium (68Ga) have undergone a significant increase in clinical utilization. 68Ga is …
with 68Gallium (68Ga) have undergone a significant increase in clinical utilization. 68Ga is …
The Diversity of 68Ga-Based Imaging Agents
I Velikyan - Theranostics, Gallium-68, and Other Radionuclides: A …, 2013 - Springer
Abstract Development of new radiopharmaceuticals and their availability are crucial factors
influencing the expansion of clinical nuclear medicine. The number of new 68 Ga-based …
influencing the expansion of clinical nuclear medicine. The number of new 68 Ga-based …
[HTML][HTML] Good practices for 68Ga radiopharmaceutical production
Abstract Background The radiometal gallium-68 (68Ga) is increasingly used in diagnostic
positron emission tomography (PET), with 68Ga-labeled radiopharmaceuticals developed …
positron emission tomography (PET), with 68Ga-labeled radiopharmaceuticals developed …
Continued rapid growth in 68Ga applications: update 2013 to June 2014
I Velikyan - Journal of Labelled Compounds and …, 2015 - Wiley Online Library
The worldwide utilization of 68Ga‐radionuclide for the fundamental research and clinical
applications is growing exponentially. A broad range of 68Ga‐based imaging agents has …
applications is growing exponentially. A broad range of 68Ga‐based imaging agents has …
[HTML][HTML] 68Ga-DOTA and analogs: Current status and future perspectives
K Kilian - Reports of Practical Oncology & Radiotherapy, 2014 - Elsevier
The construction of the 68 Ge/68 Ga generator has increased application of
radiopharmaceuticals labeled with this isotope in medicine. 68 Ga-PET is widely employed …
radiopharmaceuticals labeled with this isotope in medicine. 68 Ga-PET is widely employed …
Positron emitting [68Ga] Ga-based imaging agents: chemistry and diversity
I Velikyan - Medicinal Chemistry, 2011 - ingentaconnect.com
Positron Emission Tomography (PET) field and, in particular utilization of 68Ga radiometal is
getting momentum. The development of new imaging agents for targeted, pre-targeted, non …
getting momentum. The development of new imaging agents for targeted, pre-targeted, non …
[PDF][PDF] An overview on Ga-68 radiopharmaceuticals for positron emission tomography applications
AR Jalilian - Iranian Journal of Nuclear Medicine, 2016 - irjnm.tums.ac.ir
Gallium-68 a positron emitter radionuclide, with great impact on the nuclear medicine, has
been widely used in positron emission tomography (PET) diagnosis of various malignancies …
been widely used in positron emission tomography (PET) diagnosis of various malignancies …
68Ga‐PET: a powerful generator‐based alternative to cyclotron‐based PET radiopharmaceuticals
M Fani, JP André, HR Maecke - Contrast media & molecular …, 2008 - Wiley Online Library
PET (positron emission tomography) is a powerful diagnostic and imaging technique which
requires short‐lived positron emitting isotopes. The most commonly used are accelerator …
requires short‐lived positron emitting isotopes. The most commonly used are accelerator …
68Ga-Labeled Radiopharmaceuticals for Positron Emission Tomography
Abstract 68 Ga is a promising emerging radionuclide for positron emission tomography
(PET). It is produced using a 68 Ge/68 Ga-generator, and thus, would enable the cyclotron …
(PET). It is produced using a 68 Ge/68 Ga-generator, and thus, would enable the cyclotron …